1. Home
  2. VALN
Logo Valneva SE

VALN

Valneva SE

as 09-02-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Founded: 2012 Country:
France
France
Employees: N/A City: N/A
Market Cap: 989.8M IPO Year: 2021
Target Price: $16.00 AVG Volume (30 days): 153.6K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.50 EPS Growth: N/A
52 Week Low/High: $3.62 - $12.25 Next Earning Date: 08-12-2025
Revenue: $230,566,060 Revenue Growth: 25.47%
Revenue Growth (this year): 15.55% Revenue Growth (next year): 23.93%

VALN Daily Stock ML Predictions

Share on Social Networks: